Annie Lambert

Compliance Clinical Program Manager

Dr. Lambert serves as Clinical Program Manager for Compliance Solutions at Wolters Kluwer. Over her 20-year career, Dr. Lambert has focused on health systems pharmacy clinical programs, operations, and technology implementation primarily in oncology and infusion services. These responsibilities included development and implementation of policies, procedures and education, as well as coordination of the remodel of multiple facilities to meet USP compliance standards across both acute and ambulatory care areas, as well as retail pharmacies and clinics. Dr. Lambert expanded on her experience by serving as a consultant for USP compliance to clients across the country. She is Board Certified in Sterile Compounding Pharmacy. Dr. Lambert is passionate about medication safety for both employees and patients. She has been involved in legislation and presented on USP standards at multiple programs, as well as participated in NIOSH hazardous drug review and advocacy events on safe handling of hazardous drugs. She enjoys partnering with leaders and colleagues to share best practices to support USP compounding compliance. Dr. Lambert received her PharmD from Washington State University and completed a PGY1 residency in pharmacy practice at MultiCare Health System.

George Smith

System Sterile Compounding Services Specialist

George R. Smith, Pharm.D., BCPS, BCSCP, is currently serving as the System Sterile Compounding Services Specialist at Prisma Health, a 3200-bed health-system in South Carolina and Tennessee. In a sterile compounding career that has spanned over 20-years, Dr. Smith has held many leadership roles transversing home infusion, sterile compounding automation to health-system pharmacy. Dr. Smith is double board-certified in pharmacotherapy (BCPS) and sterile compounding (BCSCP) through the Board of Pharmacy Specialties. In his current Prisma Health role, Dr. Smith oversees 25 sterile compounding areas, including 2 centralized compounding suites and 6 ambulatory oncology infusion facilities. Prior to returning to Prisma Health in in 2023, Dr. Smith was the Director and Pharmacist Consultant of a robotic sterile compounding automation device for over 6 years where he gained and enhanced his expertise in cleanroom design, USP <797> Category 3 compounding operations, process validation, product development and Good Manufacturing Practices (GMP) in the 503B Outsourcing Facility space. Dr Smith is also serving as a Clinical Instructor of Sterile Compounding for the Kennedy Pharmacy Innovation Center at the University of South Carolina College of Pharmacy. Dr. Smith is as a current member of the ASHP Section of Inpatient Pharmacists Section Advisory Group for Compounding Practice, an AJHP peer reviewer and a field-tester for ASHP’s Compounded Sterile Preparation Intensive Studies for Recertification. Additionally, Dr. Smith is a selected member of the USP Compounding Expert Committee for the 2025-2030 cycle and an appointed member of the South Carolina Board of Pharmacy Compounding Committee for Sterile Compounding.

Mark Wiencek

Principal Microbiologist

Mark Wiencek is the Principal Microbiologist with Contec Healthcare. After receiving a Ph.D. in Microbiology from the University of Maryland, he has spent the last 30 years focusing on reducing the risk from objectionable microbes and hazardous drugs. Research interests include the development of cleaning tools and chemistries for the control of microbial and hazardous drug contamination in cleanrooms, pharmacies, and healthcare facilities. A co-author of over a dozen peer-reviewed publications, Mark is a frequent presenter with several technical and trade organizations.

Kate Douglass

Sterile Compounding Expert

Kate Douglass, MS, RN has over 30 years’ experience in sterile compounding. Past positions include VP/Chief Learning Officer at CriticalPoint, LLC; Senior VP of Clinical Operations for Coram Healthcare and COO for SoluNet, a licensed pharmacy and FDA registered manufacturing operation. Kate has authored numerous articles on sterile compounding quality and training and has personally supervised the design, engineering and build of pharmacy compounding facilities that met or exceeded USP requirements.